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igh mobility group box 1 (HMGB1) is an abundant
 
chromatin protein that acts as a cytokine when
released in the extracellular milieu by necrotic
and inﬂammatory cells. Here, we show that extracellular
HMGB1 and its receptor for advanced glycation end
products (RAGE) induce both migration and proliferation of
vessel-associated stem cells (mesoangioblasts), and thus
may play a role in muscle tissue regeneration. In vitro,
HMGB1 induces migration and proliferation of both adult
and embryonic mesoangioblasts, and disrupts the barrier
function of endothelial monolayers. In living mice, mesoan-
gioblasts injected into the femoral artery migrate close to
H
 
HMGB1-loaded heparin-Sepharose beads implanted in
healthy muscle, but are unresponsive to control beads.
Interestingly, 
 
 
 
-sarcoglycan null dystrophic muscle contains
elevated levels of HMGB1; however, mesoangioblasts
migrate into dystrophic muscle even if their RAGE receptor
is disabled. This implies that the HMGB1–RAGE interaction
is sufﬁcient, but not necessary, for mesoangioblast homing;
a different pathway might coexist. Although the role of
endogenous HMGB1 in the reconstruction of dystrophic
muscle remains to be clariﬁed, injected HMGB1 may be
used to promote tissue regeneration.
 
Introduction
 
High mobility group box 1 protein (HMGB1; also called
amphoterin) is a very abundant chromatin-binding protein
residing in the eukaryotic cell nucleus and acting in the
assembly of nucleoprotein complexes (Bustin, 1999; Agresti
and Bianchi, 2003). There are three HMGB proteins, with
 
 
 
80% amino acid identity among them; all are composed
of two basic DNA-binding domains (HMG boxes A and B)
and a long acidic COOH-terminal tail. HMGB1 is almost
ubiquitous (Guazzi et al., 2003), and HMGB2 and HMGB3
are expressed during embryogenesis and have a very restricted
expression pattern in adults (Vaccari et al., 1998; Ronfani et
al., 2001). Further to binding to DNA, HMGB1 interacts
with several transcription factors, viral replication proteins,
the RAG1 recombinase, and steroid receptors, playing a
crucial role in transcription (for review see Agresti and Bianchi,
2003). The phenotype of 
 
Hmgb1
 
 knockout mice revealed that
the gene is essential; mice die soon after birth, and have defects
in the function of steroid receptors (Calogero et al., 1999).
Recently, several groups showed that HMGB1 has an
extracellular role as a cytokine: (1) HMGB1 is secreted by
macrophages and monocytes activated by IL-1
 
 
 
, TNF, or
lipopolysaccharide (LPS; Wang et al., 1999; Andersson et
al., 2000); (2) acts as a chemoattractant for myeloid cells
(Abraham et al., 2000; Andersson et al., 2000) and smooth
muscle cells (Degryse et al., 2001); (3) enhances the ex-
pression of vascular adhesion molecules in endothelial cells
(Fiuza et al., 2003); and (4) impairs the barrier function of
intestinal epithelia (Sappington et al., 2002). Most or all of
these actions are initiated by binding of HMGB1 to the
receptor for advanced glycation end products (RAGE), a
multiligand receptor of the immunoglobulin superfamily
(Hori et al., 1995).
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Recently, we showed that necrotic cells release HMGB1
by simple diffusion, and thereby trigger inflammation; in
contrast, apoptotic cells avidly retain HMGB1 bound to
chromatin remnants even after their eventual lysis (Scaffidi
et al., 2002). Monocytic cells actively secrete HMGB1 in a
process that is independent from the ER and the Golgi ap-
paratus, but depends on HMGB1 relocalization from the
nucleus to special organelles, the secretory lysosomes (Gar-
della et al., 2002). Importantly, the secretion process re-
quires the acetylation of HMGB1 on several specific lysine
residues (Bonaldi et al., 2003). Thus, HMGB1 passively re-
leased from necrotic cells and HMGB1 actively secreted by
inflammatory cells are molecularly different.
We have argued that extracellular HMGB1 is primarily a
signal of tissue damage, and monocytes and macrophages
have “learned” to mimic an ancient alarm signal (Scaffidi et
al., 2002; Bonaldi et al., 2003). Presently, we build over this
hypothesis. A signal of tissue damage is expected to promote
the migration of stem cells to the damaged tissue, and to
promote their proliferation. Stem cells migrate during nor-
mal and pathological conditions and do proliferate during
tissue repair, but little is known about the mechanisms regu-
lating these processes (Ferrari et al., 1998; Orlic et al., 2001;
LaBarge and Blau, 2002; Vicario-Abejon et al., 2003). Here,
we show that HMGB1 acts as a mitogenic and chemoattrac-
tant factor for embryonic and adult mesoangioblasts, both in
vitro and in vivo.
Mesoangioblasts are a specific population of mesodermal
stem cells that are associated to the wall of fetal and postnatal
vessels (Minasi et al., 2002), and may derive from a primitive
angioblast (Cossu and Bianco, 2003). Mesoangioblasts ex-
press angioblast markers such as Sca-1, Flk-1, and CD34, as
well as genes typical of the mesoderm, including receptors
and signaling molecules for classical mesoderm inducers,
such as BMP, Wnt, and Notch (unpublished data). Mesoan-
gioblasts can be grown extensively in culture (
 
 
 
50 passages)
and are able to differentiate into most mesodermal cell types;
most notably, they are able to home to damaged tissue mus-
cle, and participate in muscle regeneration (Sampaolesi et al.,
2003). Thus, they are ideal to study stem cell homing in vivo.
When injected into arteries of 
 
 
 
-sarcoglycan (
 
 
 
-SG) null
mice, a model for limb-girdle muscular dystrophy, mesoan-
gioblasts accumulate in the first capillary filter they encoun-
ter, migrate outside of the vessel into the areas of muscle
wastage and inflammation, and eventually correct morpho-
logically and functionally the dystrophic phenotype (Sampao-
lesi et al., 2003). The nature of the molecules that chemoat-
tract mesoangioblasts where they are required was unknown.
Here, we show that unmodified, bacterially made HMGB1
is sufficient to attract mesoangioblasts, both in vitro and when
injected into healthy muscle. However, mesoangioblasts ex-
pressing a dominant-negative mutant of RAGE (dnRAGE),
the only receptor for HMGB1 identified so far, still find their
way into dystrophic muscle. These data indicate that meso-
angioblasts can use receptors other than RAGE to navigate
to dystrophic muscle. In turn, this may mean that dystro-
phic muscle recruits mesoangioblasts via as yet unidentified
chemoattractants, or that acetylated HMGB1 secreted by in-
flammatory cells is indeed the chemoattractant released by dys-
trophic muscle, but is recognized by a receptor different from
RAGE. Bacterially made HMGB1 may be used experimen-
tally or therapeutically to direct mesoangioblast migration into
nondystrophic muscle, or to enhance it in dystrophic muscle.
 
Results
 
HMGB1 stimulates the proliferation of vessel-associated 
embryonic stem cells
 
Stem cells isolated from mouse dorsal aorta of E9.5 C57Bl6
mouse embryos (mesoangioblasts) were cultured in vitro and
tested for the presence of the CD34, Sca1, Flk1, and
MEF2D cellular markers (Minasi et al., 2002). We used one
of these clones (called D16; Sampaolesi et al., 2003) to assess
whether HMGB1 can act as a mitogen.
D16 cells were seeded in RPMI medium with 20% FCS
and then starved for 16 h in the absence of serum to syn-
chronize the cell population. Increasing concentrations of
Figure 1. Effect of HMGB1 on embryonic mesoangioblast prolif-
eration. (A) D16 cells were grown in RPMI medium containing no 
addition, HMGB1 at the indicated concentrations, or 20% FCS. 
HMGB1 induced cell proliferation at all concentrations tested, but 
the cell number reached a plateau after 48 h. Each point represents 
the mean   SD (n   3). The experiment was repeated three times. 
(B) D16 cell division was analyzed by FACS
®. After 6 h in the presence 
of 30 ng/ml HMGB1 the DNA content increases, but returns to the 
normal diploid content after 24 h. Asterisk indicates statistical signifi-
cance (P   0.001). (C) 3T3 fibroblasts (treated as the D16 cells in A) 
do not divide in the presence of HMGB1. 
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HMGB1 were then added to the medium without serum.
Fig. 1 A shows that there is a significant increase in the num-
ber of D16 mesoangioblasts after stimulation with HMGB1
up to d 2, whereas only slight proliferation occurs between d
2 and 3. All concentrations tested had similar effects.
HMGB1-stimulated D16 cells had a normal morphology
and excluded trypan blue up to the end of the experiment,
whereas cells in control cultures without HMGB1 were dy-
ing (unpublished data). HMGB1 has no mitogenic effect on
3T3 fibroblasts (Fig. 1 C).
We investigated in more detail the proliferative response
of D16 cells to HMGB1. Cells were exposed for 6, 12, and
24 h to RPMI medium alone (negative control) or medium
containing 30 ng/ml HMGB1 or 20% FCS, and were ana-
lyzed for DNA content by FACS
 
®
 
 after propidium iodide
staining. After 6 h of stimulation with HMGB1, the major-
ity of mesoangioblasts had entered the cell cycle; after 24 h,
most cells appeared to have a diploid DNA content and thus
to be in G1 or G0 (Fig. 1 B). We evaluated the number of
cell cycles triggered by HMGB1 by staining the cell mem-
branes at time 0 with the fluorescent dye carboxyfluorescein
diacetate succinimidyl ester (Lyons and Parish, 1994); after
48 h most cells had one-half of the initial quantity of dye
(and so had undergone one division), and a minority had
one-quarter (and had undergone two divisions). By compar-
ison, all cells cultured in 20% FCS had divided at least twice
(unpublished data).
These data indicate that HMGB1 induces a limited num-
ber of cell divisions. This might be due to a specific program
of mesoangioblasts, or to the depletion of HMGB1 in the
medium. Therefore, we added 30 ng/ml HMGB1 at time 0,
and additional HMGB1 at 12, 36, and 60 h. Mesoangio-
blasts continually exposed to HMGB1 continued to divide
(Fig. 2). After 48 h, no HMGB1 was detectable by Western
blot in the medium of cells stimulated once, whereas
HMGB1 equivalent to 
 
 
 
40 ng/ml remained in the medium
of multiply exposed cells (Fig. 2, inset). Together, these re-
sults indicate that HMGB1 acts as a growth factor for D16
cells, but is rapidly depleted.
 
HMGB1 induces mesoangioblast migration
 
Previously, we have shown that HMGB1 is a chemoattrac-
tant for rat smooth muscle cells (Degryse et al., 2001). We
then investigated whether HMGB1 is also a chemoattrac-
tant for D16 cells. In a chemotaxis assay using modified
Boyden chambers, HMGB1 stimulated migration of D16
cells in a concentration-dependent manner (Fig. 3 A). pAbs
raised against aa 166–181 of HMGB1 (Fig. 3 A, anti 166–
181) significantly reduced the migratory response. However,
the migratory response was unaffected by an anti-HMGB1
mAb that recognizes box A.
We also tested the individual domains of HMGB1 for the
ability to induce D16 cell migration (Fig. 3 B). Neither box
A nor box B alone induced appreciable migration. The dido-
main fragment (comprising boxes A and B) had a nonsignifi-
cant effect, whereas the ABbt fragment, which only lacks the
acidic tail (Fig. 3 C), was as potent as the full-length protein.
Residues 150–183 were identified as the HMGB1 segment
that interacts with RAGE (Huttunen et al., 2002). Remark-
ably, the anti-HMGB1 antibodies that block D16 migration
(Fig. 3 A) specifically interact with the amino acid stretch be-
tween residues 166 and 181 (Fig. 3 C), and therefore occlude
the RAGE-interacting surface. The mAb that recognizes box
A cannot prevent the interaction with RAGE.
These data suggested that RAGE is the receptor that me-
diates the HMGB1 chemoattractant function. In D16 cells,
RNA profiling (unpublished data) indicates that they ex-
press RAGE, and RAGE protein is detectable by Western
blot (Fig. 3 D). We then cotransfected D16 cells with plas-
mids expressing nuclear YFP and dnRAGE (lacking the in-
tracytoplasmic domain) (Hofmann et al., 1999), or with the
control empty vector. The entire cell population was sub-
jected to a chemotaxis assay with Boyden chambers; how-
ever, only yellow fluorescent cells were scored. Fig. 3 E
shows that mesoangioblasts transfected with dnRAGE were
severely impaired in their ability to respond to extracellular
HMGB1, supporting the conclusion that HMGB1 signals
prevalently through RAGE.
 
HMGB1 induces mesoangioblast migration across 
endothelial monolayers
 
Mesoangioblasts are vessel-associated stem cells that can
migrate to damaged tissues through the general circula-
tion (Sampaolesi et al., 2003), and have the ability to tran-
sit through the endothelial barrier. We tested whether
HMGB1 could also promote the transmigration of mesoan-
gioblasts across an endothelial monolayer grown on the sep-
tum between the chambers of a Boyden apparatus. When we
added 100 ng/ml HMGB1 to the medium in the lower
chamber, the number of D16 cells crossing the monolayer
increased eightfold when compared with medium without
any addition (Fig. 4). HMGB1 has higher potency than
VEGF, a signaling molecule known to promote cell migra-
tion across endothelial barriers. VEGF induces profound cy-
Figure 2. Continued HMGB1 stimulation sustains mesoangioblast 
proliferation. D16 cells were placed at time 0 in RPMI medium 
containing 30 ng/ml HMGB1; a similar amount of HMGB1 was also 
added at the times indicated with a triangle. Multiply stimulated D16 
cells kept growing. Each point represents the average   SD of two 
experiments performed in duplicate. Inset: Western blot of HMGB1 
in the medium bathing D16 cells 48 h after the beginning of the 
experiment. HMGB1 was still present in the medium of restimulated 
cells, but not in the medium of cells stimulated once at time 0. This 
experiment was repeated two times with similar results. 
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toskeletal reorganization of endothelial cells, characterized
by the formation of trans-cytoplasmic stress fibers and the
disassembly of adherens junctions, which are important to
maintain the endothelial barrier function (Esser et al., 1998;
Rousseau et al., 2000). Stimulation with HMGB1 caused a
similar response in endothelial cells grown in vitro as mono-
layers (unpublished data).
 
HMGB1 directs mesoangioblast homing in vivo
 
Next, we assessed HMGB1’s ability to control mesoangio-
blast migration in vivo. We loaded heparin-Sepharose beads
with HMGB1 at the concentration of 3 
 
 
 
g/
 
 
 
l and injected
them with a fine needle into the tibialis anterior muscle of
mice. D16 cells transduced by a lentiviral vector causing the
expression of nuclear LacZ were injected after 30 min
through the proximal femoral artery (see Materials and
methods). The mice were killed after 24 h and the tibialis
anterior muscle was removed, sectioned, and analyzed by
immunohistochemistry. Muscles injected with HMGB1-
loaded beads showed a considerable swelling compared with
both sham-injected muscles (unpublished data) and muscles
injected with unloaded heparin-Sepharose beads (Fig. 5 A),
suggesting that HMGB1 caused considerable muscle inflam-
mation. This is consistent with HMGB1’s role as a proin-
flammatory cytokine.
Muscle sections were stained with X-gal, and LacZ
 
 
 
(blue) cells were scored using computer-assisted imaging
techniques. Large groups of blue cells were found in the vi-
Figure 3. HMGB1 has chemotactic activity on embryonic mesoangioblasts. (A) D16 cells were subjected to chemotaxis assays with 10, 50, 
or 100 ng/ml HMGB1. Data represent the average   SD of four experiments performed in duplicate; the effect of increasing HMGB1 concen-
trations is highly significant (P   0.001 in ANOVA analysis). Addition of anti-HMGB1 antibodies recognizing the peptide 166–181 significantly 
reduced the chemotactic response (P   0.05 in comparison to the sample without antibody), whereas the addition of monoclonal anti-box A 
antibodies had no effect. (B) Chemotactic activity on D16 cells of various HMGB1 fragments (all at 10 ng/ml). ABbt has a chemotactic effect 
comparable with full-length HMGB1 (P   0.05 of proteins vs. medium alone). In contrast, boxes A and B and the AB didomain have no 
significant chemotactic activity. Bars represent the average   SD of three experiments performed in duplicate. Asterisks indicate statistical 
significance (P  0.01). (C) Schematic representation of full-length HMGB1, boxes A and B, the didomain AB, and tailless HMGB1 (ABbt). 
(D) Western blot with anti-RAGE antibodies on total D16 cell extract. (E) D16 cells transfected with dnRAGE-expressing plasmid or pCDNA3 
empty vector were assayed for chemotaxis in response to medium with or without HMGB1. Cells transfected with dnRAGE exhibited a significant 
decrease in migration in comparison to cells transfected with control plasmid. Asterisks indicate statistical significance (P   0.05).
Figure 4. HMGB1 induces the transit of mesoangioblasts through 
an endothelial monolayer. D16 cells were placed in the upper 
compartment of Boyden apparatuses. The lower chambers contained 
RPMI alone (medium), RPMI plus 100 ng/ml HMGB1, or RPMI plus 
10 ng/ml VEGF; chambers were separated by a confluent endothelial 
cell monolayer grown on polycarbonate filters. HMGB1 significantly 
stimulated D16 transmigration (P   0.01). Bars represent the aver-
age   SD of three experiments performed in duplicate. Panels
beside the bar graph show D16 cells stained with Giemsa after 
migration, toward medium alone or containing HMGB1. Asterisk 
indicates statistical significance (P   0.05). 
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cinity of HMGB1-loaded beads (Fig. 5 C); a minority of
sections displayed individual blue cells dispersed throughout
the muscle (Fig. 5 D). The sections from muscles injected
with unloaded beads had no blue cells at all (Fig. 5 B).
The number of mesoangioblasts colonizing healthy muscle
implanted with HMGB1-loaded beads compares well with
the number of mesoangioblasts homing into dystrophic mus-
cle (Fig. 5 E). Inflammation was present in both HMGB1-
treated wild-type and 
 
 
 
-SG null muscle, and may be necessary
to promote mesoangioblast invasion. However, inflammation
by itself is not sufficient. Heparin-Sepharose beads injected
together with 1 
 
 
 
g LPS in healthy muscle did cause inflam-
mation and tissue swelling (unpublished data), but did not at-
tract any mesoangioblast (Fig. 5 E). These observations indi-
cate that HMGB1 is able to recruit mesoangioblasts in vivo.
 
The biological action of HMGB1 on adult 
mesoangioblasts and lin
 
 
 
 hematopoietic stem cells
 
The previous experiments identified a role for extracellular
HMGB1 on the migration and proliferation of embryonic
mesoangioblasts. Next, we asked whether HMGB1 had an
effect on adult mesoangioblasts as well. We used adult me-
soangioblasts isolated from bone marrow (G1 clone; see Ma-
terials and methods); these cells express the same markers
(CD34, Flk-1, Sca-1, and MEF2D) and show similar differ-
entiation potency and comparable growth rate as mesoan-
gioblasts isolated from embryos (unpublished data). Fig. 6
summarizes our findings. HMGB1 causes adult mesoangio-
blast proliferation (Fig. 6 A), chemotaxis, and transmigra-
tion (Fig. 6 B); like embryonic mesoangioblasts, adult ones
can be recruited by HMGB1 into the tibialis anterior muscle
(Fig. 6 C). Similar effects were also observed in additional
experiments with different adult mesoangioblast lines de-
rived from the aorta of 8-wk-old mice (unpublished data).
We then tested whether HMGB1 could also attract other
types of stem cells. We injected a similar number of murine
 
lineage-negative (lin
 
 
 
) hematopoietic stem cells in the femo-
ral artery of mice that had been implanted with HMGB1-
loaded beads. A few cells were indeed found around the beads
(unpublished data), indicating that HMGB1 may have a gen-
eral chemoattractant activity toward all or many types of stem
cells. However, the response was quantitatively far less robust;
 
 
 
10-fold fewer hematopoietic cells migrated to the vicinity
of beads compared with mesoangioblasts. This may be due to
a quantitative difference of the chemoattractant properties of
HMGB1 toward different stem cells, or to the different abil-
ity of stem cells to traverse the endothelium and invade mus-
cle tissue. In fact, mesoangioblasts colonize dystrophic muscle
in the mouse model of limb-girdle dystrophy much better
than hematopoietic stem cells (unpublished data).
 
Mesoangioblasts expressing dnRAGE still home 
to dystrophic muscle
 
We chose mesoangioblasts as the object of our experiments
precisely because they have the ability to navigate to dys-
trophic muscle; furthermore, the experiments shown
above indicate that mesoangioblasts respond to extracellular
HMGB1 in healthy muscle. Is then HMGB1 relevant for
mesoangioblast homing to dystrophic muscle?
Both dystrophic and healthy muscles contain HMGB1,
but HMGB1 is much more abundant in dystrophic muscle,
as assayed by Western blot (Fig. 7 A). By immunohis-
tochemistry (Fig. 7 B), it appears that both healthy and dys-
trophic muscle cells contain a similar amount of HMGB1 in
their nuclei. However, infiltrating cells in dystrophic muscle
contain a large amount of HMGB1, both in the cytoplasm
and in the nucleus. The cytoplasmic location of HMGB1
indicates that inflammatory cells are activated, and that they
have acetylated HMGB1 extensively (Gardella et al., 2002;
Bonaldi et al., 2003).
Next, we injected into the femoral artery of 
 
 
 
-SG
 
 
 
/
 
 
 
 mice
a mesoangioblast population that had been transfected with
Figure 5. HMGB1 attracts mesoangio-
blasts in vivo. D16 cells were first trans-
duced with a lentiviral vector encoding 
nuclear LacZ, and were then injected 
through the femoral artery of mice where 
heparin-Sepharose beads (either unloaded 
or loaded with HMGB1) had been in-
jected in the tibialis anterior muscle. Mice 
were killed after 24 h. (A) Tibialis anterior 
muscles injected with HMGB1-loaded 
and control beads. (B–D) Cryosections 
of muscles treated with control heparin-
Sepharose beads (control) or HMGB1-
coated heparin-Sepharose beads 
(HMGB1). Arrows indicate the beads. Sections were stained with X-gal, 
and mesoangioblasts (arrowheads) appear blue. Mesoangioblasts were 
found in large clusters (C) or as isolated cells (D) only in muscles injected 
with HMGB1-coated beads. (E) Number of migrating D16 cells in tibialis 
anterior muscles of wild-type mice treated with HMGB1-loaded beads 
(gray bar; n   2) or control beads coinjected with 1  g LPS (black bar; n   3). 
White bar represents the number of D16 cells found in tibialis anterior 
muscles of  -SG
 /  dystrophic mice (n   2). 
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dnRAGE receptor and GFP. About 30% of cells expressed
dnRAGE and GFP (green), and were unresponsive to bacte-
rially made HMGB1 in vitro (Fig. 3 E) and in healthy
muscle (unpublished data); all cells were also labeled with
1,1
 
 
 
-dioctadecyl-3,3,3
 
 
 
,3
 
 
 
-tetramethylindocarbocyanine per-
chlorate (DiI; red). After homing to the dystrophic tissue,
the ratio of green to red cells was again 
 
 
 
30% (Fig. 7 C).
This experiment indicates that mesoangioblasts do not need
the RAGE receptor to home into dystrophic muscle. When
we injected dystrophic muscles with HMGB1-loaded and
control beads, many more mesoangioblasts homed to the
HMGB1-loaded beads (Fig. 7 D). However, about the
same number of dnRAGE-expressing green mesoangioblasts
homed to control and HMGB1-loaded beads; the excess
Figure 6. Effect of HMGB1 on adult 
mesoangioblasts. (A) Mesoangioblasts of 
the G1 clone, obtained from mouse bone 
marrow, were grown in RPMI medium 
containing 1, 10, or 30 ng/ml HMGB1. 
For comparison, G1 cells were also grown 
in RPMI medium alone or in RPMI plus 
20% FCS. (B) Migration of G1 cells toward 
the lower chamber of Boyden apparatuses 
containing RPMI (medium) or RPMI plus 
10 ng/ml HMGB1 (HMGB1). In the 
migration experiment, the chambers were 
separated by a filter; in the transmigration 
experiment, the chambers were separated 
by a filter overgrown with a monolayer 
of endothelial cells. Each bar represents 
the average   SD of three experiments, 
and the arrows indicate statistical sig-
nificance (P   0.05). (C) G1 cells were 
labeled with DiI and then injected through 
the femoral artery of mice where heparin-
Sepharose beads (either loaded with 
HMGB1 or unloaded) had been implanted 
in the tibialis anterior muscle (arrows). 
Top, phase contrast; bottom, fluorescence. 
G1 cells (red fluorescence) migrate in the 
vicinity of HMGB1-loaded cells; no G1 
cells are detected near control beads.
Figure 7. HMGB1 expression and mesoangioblast migration in  -SG
 /  dystrophic muscles. (A) Western blot analysis of HMGB1 expression 
levels in tibialis anterior muscles from  -SG
 /  dystrophic and wild-type mice. (B) Hematoxylin and eosin staining (H&E) of tibialis anterior 
muscle sections from  -SG
 /  dystrophic and wild-type mice. Different sections from the same muscles were processed for immunofluorescence 
(right). A considerable number of foci containing inflammatory cells were evident in  -SG
 /  dystrophic muscles, and these contained HMGB1 
in the cytoplasm in addition to the nucleus (anti-HMGB1, green; DAPI, red pseudocolor). (C) Fraction of dnRAGE expressing D16 cells before 
and after injection and homing to tibialis anterior muscles of  -SG
 /  dystrophic mice. About 500 cells were counted before and after injection 
in two mice. The difference before and after migration is not statistically different. (D) Number of migrating D16 cells in tibialis anterior 
muscles of  -SG
 /  dystrophic mice injected with control beads (n   2) or HMGB1-loaded beads (n   2). Cells expressing dnRAGE and GFP 
are indicated in green; the nonexpressing cells are indicated in gray. The difference in total number of cells, and in cells not expressing dnRAGE, 
is significant (P   0.05). The difference in cells expressing dnRAGE is not statistically significant. 
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mesoangioblasts homing to HMGB1-loaded beads were red.
Thus, mesoangioblasts can indeed use the RAGE receptor to
home to the vicinity of injected unmodified HMGB1, even
in dystrophic muscle.
 
Discussion
 
The discovery that necrotic cells release HMGB1 in the ex-
tracellular space, whereas apoptotic cells do not, led us to
propose that extracellular HMGB1 is a signal of tissue dam-
age (Scaffidi et al., 2002; Bianchi and Manfredi, 2004).
Here, we have tested a stringent prediction: a signal of tissue
damage should recruit stem cells, and should promote their
proliferation. We have used mesoangioblasts because they
can migrate inside damaged muscle and proliferate there to
reconstruct the tissue (Sampaolesi et al., 2003).
Mesoangioblasts migrate in vitro in response to HMGB1
gradients, and proliferate in vitro in response to a continuing
supply of HMGB1 as sole mitogenic factor in serum-free
medium. RAGE appears to be the receptor involved: (1) the
segment of HMGB1 protein required for mesoangioblast
migration coincides with the segment required for RAGE
signaling (Huttunen et al., 2002); (2) RAGE protein and
mRNA are present in mesoangioblasts; and (3) dnRAGE
significantly reduces the response of mesoangioblasts to
HMGB1. In vitro, HMGB1 also induces the loss of cell–cell
contacts in endothelial cell monolayers, and impairs their
barrier function against the transit of cells.
The in vitro findings suggest that HMGB1 might have
the characteristics required to attract mesoangioblasts in
vivo. Thus, we performed an experiment where mesoangio-
blasts were injected in the femoral artery (and thus accumu-
lated in the microvascular compartment of downstream
skeletal muscles) while HMGB1 was released by beads im-
planted into the tibialis anterior muscle. Mesoangioblasts
did migrate to the vicinity of HMGB1-loaded beads.
HMGB1 binds tightly to heparin (Bianchi, 1988), and it
is difficult to measure or estimate the concentration of
HMGB1 released locally in the muscle tissue. However, we
can roughly estimate that each heparin-Sepharose bead con-
tained 
 
 
 
25 pg HMGB1, the equivalent of 50 nuclei, and
that only a fraction of this would be released. Remarkably,
the HMGB1 released in healthy muscle tissue under these
conditions is able to promote both significant inflammation
(as shown by fluid retention in the muscle and the recruit-
ment of inflammatory cells around the HMGB1-loaded
beads) and the recruitment of mesoangioblasts. Control
beads recruited no mesoangioblasts, even when inflamma-
tion was elicited by coinjected LPS.
We also tested whether HMGB1 is able to attract hemato-
poietic stem cells. Lin
  cells derived from bone marrow did
home to the vicinity of HMGB1-loaded beads, but their
quantitative response was far below that of mesoangioblasts.
Hematopoietic stem cells also have a reduced ability to home
to dystrophic muscle (unpublished data). We do not know
with certainty whether this is due to a lower chemoattractant
activity of HMGB1 toward lin
  cells or to a reduced ability of
lin
  cells to home to the interior of muscle tissue. There is a
clear possibility that other types of stem cells might also use
extracellular HMGB1 as a cue to homing to damaged tissue.
The role of the HMGB1–RAGE interaction in the 
homing of mesoangioblasts to dystrophic muscle
Mesoangioblasts can home into dystrophic muscle (Sam-
paolesi et al., 2003), and our data identify extracellular
HMGB1 and RAGE as a ligand/receptor pair sufficient for
mesoangioblast homing in vivo. However, contrary to ex-
pectations, mesoangioblasts expressing dnRAGE also home
into dystrophic muscle. The HMGB1–RAGE interaction is
thus sufficient, but not necessary, in dystrophic muscle. This
is indeed puzzling, and we discuss possible explanations.
The simplest explanation is that dystrophic muscle con-
tains a lot of HMGB1, but such HMGB1 is entirely intra-
cellular, either because inflammatory cells retain HMGB1
rather than secreting it, or because secreted HMGB1 is im-
mediately destroyed. Infiltrating cells in dystrophic muscle
cells contain HMGB1 in the cytoplasm, an indication that
they are activated. However, HMGB1 secretion requires at
least two signals: an inflammatory signal promotes HMGB1
acetylation and its relocation from the nucleus to the cyto-
plasm and into secretory vesicles (Bonaldi et al., 2003), and
a secretion signal (extracellular ATP or lysophosphatidylcho-
line) promotes exocytosis (Gardella et al., 2002). The secre-
tory signal may be absent in dystrophic muscle.
A second possibility is that HMGB1 is secreted by inflam-
matory cells, but acetylated HMGB1 attracts mesoangio-
blasts via an as yet unidentified receptor. In other words,
RAGE would be activated by unmodified HMGB1, but not
by acetylated HMGB1.
A third possibility is that dystrophic muscle uses an as yet
unidentified chemoattractor (different from HMGB1 and
binding to a receptor different from RAGE) to attract me-
soangioblasts. The existence of a parallel signaling pathway
that does not require HMGB1 as one of its signaling compo-
nents would be required if no HMGB1 is released within dys-
trophic muscle, but is still very possible even if acetylated or
unmodified HMGB1 is indeed released in dystrophic muscle.
None of these possible explanations is easily testable for
the time being: (1) we have no way to determine whether
HMGB1 is secreted by inflammatory cells in dystrophic
muscle (assays for HMGB1 in blood have insufficient sensi-
tivity); (2) the form of HMGB1 secreted by inflammatory
cells and acetylated on specific lysines cannot be produced in
meaningful amounts; and (3) alternative chemoattractors for
mesoangioblasts have not been identified yet. However, the
recognition that unmodified HMGB1 is sufficient to attract
mesoangioblasts both in healthy and dystrophic muscle is
highly valuable. Unmodified HMGB1 can be produced in
bacteria in unlimited amounts, and can be used as a tool for
research in stem cell mobilization, and potentially to im-
prove the reconstruction of dystrophic muscle.
Materials and methods
HMGB1 and antibodies
Expression and purification of the full-length HMGB1 protein and frag-
ments thereof was performed as described previously (Müller et al., 2001).
Endotoxins were removed by passage through Detoxy-Gel columns (Pierce
Chemical Co.).
Rabbit polyclonal anti-HMGB1 antibodies raised against peptide 166–
181 were purchased from BD Biosciences, pAbs against box A were pur-
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was purchased from CHEMICON International. Western blots were per-
formed as described previously (Degryse et al., 2001), and films were
scanned on a color scanner (StudioStar; Agfa).
Cells
Bovine aorta endothelial cells were isolated from a section of the thoracic
aorta of a freshly slaughtered calf as described previously (Palumbo et al.,
2002). Mesoangioblast cell lines were isolated from the dorsal aorta of
mouse embryos (D16) or bone marrow (G1), cloned, and expanded as de-
scribed previously (Minasi et al., 2002). Clones were checked for the pres-
ence of CD34, Kit, Flk1, and MEF2D markers. For the in vivo experiments,
embryonic mesoangioblasts (D16) were transduced with a lentiviral vector
encoding for nuclear LacZ, whereas adult mesoangioblasts (G1) were la-
beled with DiI (Molecular Probes, Inc.).
Lin
  cells were isolated from CD-1 mice using the SpinSep™ kit (Stem-
Cell Technologies Inc.) according to the manufacturer’s instructions. In
brief, 2   10
7 bone marrow cells, obtained by flushing femurs and tibias
with PBS containing 2% FCS, were subjected to centrifugation and were
resuspended in 1 ml of the same flushing buffer; 10  l SpinSep™ antibody
cocktail (containing antibodies against CD5, CD45R, CD11b, TER 119,
Gr-1, and neutrophils) was added to the cell suspension and incubated at
4 C for 30 min. After washing, 100  l of the SpinSep™-dense particles was
added to the cells and incubated on ice for 20 min. Cells were then diluted
and layered on top of 4 ml SpinSep™ density medium and centrifuged for
10 min at 1,200 g at RT. The cell fraction enriched for hematopoietic pro-
genitors (0.11–1.3   10
6 cells) was located in the interface between layers.
After washing, cells were used for intra-arterial delivery.
Proliferation assay
Cells were seeded in 6-well plates (10
5 cells/well) and grown in RPMI sup-
plemented with 20% FCS. After 24 h, the medium was replaced with se-
rum-free RPMI for 16 h. Subsequently, the cells were grown with medium
alone, or medium with the addition of 20% FCS or HMGB1 at the concen-
tration of 1, 3, 10, and 30 ng/ml. Cells were counted after 1, 2, and 3 d,
and trypan blue dye exclusion was used as an indicator of cell viability. All
experiments were performed three times in duplicate.
Flow cytometry
Mesoangioblasts starved overnight were grown in RPMI medium alone,
RPMI plus 20% FCS, or RPMI plus 100 ng/ml HMGB1 for 6, 12, 24, or
48 h. Cells were washed, fixed in 70% ethanol, stained with 50  g/ml pro-
pidium iodide in PBS plus 50  g/ml RNase A, and incubated for 30 min at
RT. The DNA content was measured by flow cytometry (FACScan™; Bec-
ton Dickinson) using the standard CellQuest software.
Estimation of the number of cell divisions
One million embryonic or adult mesoangioblasts were seeded on 100-mm
dishes in RPMI supplemented with 20% FCS. After 24 h, the cells were
starved in RPMI alone overnight. Cells were then washed in PBS, and 2.5
 M carboxyfluorescein diacetate succinimidyl ester (Molecular Probes,
Inc.) was added for 8 min at RT. Staining was quenched by the addition of
10% FCS, and cells were washed in RPMI. Fluorescently labeled cells
were then grown in RPMI alone, RPMI plus 100 ng/ml HMGB1, or RPMI
plus 20% FCS, and were harvested after 48 h. Cells were then analyzed on
FACScan™.
Chemotaxis assay
Cell migration was assayed using Boyden chambers (Degryse et al., 2001).
In brief, PVP-free polycarbonate filters with 8- m pores (Costar) were
coated with 5  g/ml porcine skin gelatin (Sigma-Aldrich). Serum-free RPMI
(negative control), RPMI containing 10, 50, or 100 ng/ml HMGB1, and
RPMI with 20% serum (positive control) were placed in the lower cham-
bers. D16 cells were grown in RPMI plus 10% FCS, starved overnight,
washed twice with PBS to eliminate any floating cells, and harvested with
trypsin. 50,000 cells resuspended in 200  l RPMI were placed in the up-
per chambers and incubated at 37 C in 5% CO2 for 16 h. Cells remaining
on the upper surface of the filters were mechanically removed, and those
which had migrated to the lower surface were fixed with ethanol, stained
with Giemsa stain (modified; Sigma-Aldrich), and counted at 400  in 10
random fields per filter. Assays were performed in triplicate and repeated
three times in independent experiments.
Transmigration assay
Bovine aorta endothelial cells were grown in DME plus 10% FCS on poly-
carbonate transwell inserts (3- m pores; Costar) for 5 d until they formed a
monolayer. The inserts were then placed between chambers in Boyden ap-
paratuses, and the tightness of monolayers was checked by measuring the
diffusion of BSA between chambers. Mesoangioblasts (10
5 cells in 100  l
RPMI) were placed in the upper compartments, and RPMI containing
HMGB1 or VEGF (mature 121 aa variant of human VEGF expressed in
Escherichia coli, purchased from R&D Systems) was placed in the lower
compartments (500  l). After 8 h at 37 C, the filters were removed and the
result was evaluated as described for the chemotaxis assay. These experi-
ments were performed three times in duplicate.
Cell transfection
dnRAGE is a RAGE truncation lacking the entire intracytoplasmic domain
(Hofmann et al., 1999). pNLS1-YFP was constructed like pNLS1-GFP
(Bonaldi et al., 2003). One million D16 cells were cotransfected with 1  g
pNLS1-YFP and 3  g plasmid encoding dnRAGE or pCDNA3 empty vector,
using FuGENE™ reagent (Roche). After 24 h, the medium was replaced with
RPMI plus 20% FCS; after an additional 24 h, the chemotaxis assay was per-
formed as described above. Only YFP-positive cells were considered.
In the mesoangioblast homing experiment, cells were transfected in a
similar way, but using pNLS1-GFP instead of pNLS1-YFP, and were then
labeled with DiI. The ratio of green to red cells was evaluated by counting
 500 cells before and after injection and homing.
Preparation of HMGB1-loaded beads
34- m-diam heparin-Sepharose beads were recovered from a HiTrap™
heparin HP column (Amersham Biosciences) and were extensively washed
in PBS. Beads (20  l packed volume) were then incubated for 1 h at 4 C
with 60  g HMGB1, harvested by centrifugation, washed twice with PBS,
and resuspended in PBS. SDS-PAGE was performed to check the amount
of HMGB1 on the beads.
Intra-artery delivery of stem cells in mice
Heparin-Sepharose beads (a slurry containing 3  g beads in 20  l PBS), ei-
ther loaded with HMGB1 or not, were injected with an insulin syringe into
tibialis anterior muscles of 6-wk-old female CD-1 mice (three per group).
After 1 h, mesoangioblasts or hematopoietic stem cells (4   10
5 cells/animal)
were injected through the femoral artery as described previously (Torrente
et al., 2001); animals were killed 24 h later. For histochemistry analysis,
samples of tibialis anterior muscles were frozen in liquid nitrogen–cooled
isopentane and were cryostat sectioned. 10- m thick serial muscle sec-
tions were stained with X-gal for the experiment with LacZ-labeled cells
(Totsugawa et al., 2002), or visualized directly under the fluorescence mi-
croscope for the experiment with DiI, and GFP was indicated.
Immunofluorescence and immunoblots to detect 
HMGB1 in muscle
Tibialis anterior muscles of  -SG
 /  and C57Bl6 wild-type mice were re-
moved after bead implantation and mesoangioblast injection, frozen in
liquid nitrogen, and cryostat sectioned. Serial muscle sections were fixed
in 4% PFA, permeabilized, saturated, and processed for immunofluores-
cence with rabbit anti-HMGB1 antibody (1:500 dilution) followed by Al-
exa Fluor
® 488–conjugated goat anti–rabbit Ig (Molecular Probes, Inc.).
Images were taken with a microscope (S100 TV; Carl Zeiss MicroImaging,
Inc.) equipped with a 32 /0.4 Ph2 LD Achroplan objective (Carl Zeiss
MicroImaging, Inc.).
For immunoblots, whole tibialis anterior muscles were removed and
homogenized in PBS containing Protease Inhibitor Cocktail (Sigma-
Aldrich). Protein concentrations were measured using a Bradford assay.
Immunoblotting was performed using rabbit anti-HMGB1 (BD Biosciences)
and anti-  tubulin (Sigma-Aldrich) antibodies.
Digital images
Digital images were elaborated using Adobe Photoshop
®, and included in
figures using Adobe Illustrator
®.
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